November 25, 2025 — Leads & Copy —
Immunome, Inc. (Nasdaq: IMNM) will participate in two upcoming healthcare conferences, the Piper Sandler 37th Annual Healthcare Conference and the 8th Annual Evercore Healthcare Conference.
Immunome’s management is scheduled to present at both conferences on December 3, 2025. The Piper Sandler presentation will take place at 9:00 a.m. ET, followed by the Evercore presentation at 9:10 a.m. ET.
Interested parties can access live audio webcasts of the presentations in the Investor Relations section of Immunome’s website. Replay webcasts will be available on the company’s website for roughly 30 days after the live events.
Immunome is a clinical-stage oncology company focused on developing first-in-class and best-in-class targeted therapies for cancer patients.
The company’s pipeline includes varegacestat, a gamma secretase inhibitor in Phase 3 for desmoid tumors; IM-1021, a ROR1-targeted ADC in Phase 1; and IM-3050, a FAP-targeted radioligand that recently received IND clearance. The pipeline also includes preclinical ADCs, IM-1617, IM-1335, and IM-1340, targeting undisclosed solid tumor expressions.
Source: Immunome, Inc.
